Growth Hormone in EB

NCT05390073 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2022-05-25

No results posted yet for this study

Summary

Growth is extremely affected in epidermolysis bullosa patients

Conditions

  • Epidermolysis Bullosa Dystrophica

Interventions

DIAGNOSTIC_TEST

growth hormone level and insulin like growth factor 1

laboratory test

Sponsors & Collaborators

  • Cairo University

    lead OTHER

Eligibility

Min Age
1 Month
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-25
Primary Completion
2022-06-10
Completion
2022-06-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05390073 on ClinicalTrials.gov